Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,179 | 19,501 | 23,811 | 19,360 | 27,613 |
| Receivables | 34,043 | 25,547 | 27,924 | 21,712 | 27,613 |
| Inventories | 13,637 | 12,950 | 12,871 | 10,849 | 13,891 |
| Other current assets | 1,177 | 624 | 785 | 633 | 888 |
| TOTAL | $78,465 | $70,611 | $74,415 | $59,929 | $77,947 |
| Non-Current Assets | |||||
| PPE Net | 2,028 | 2,344 | 2,672 | 3,025 | 3,479 |
| Intangibles | 63,464 | 64,985 | 69,108 | 70,632 | 83,065 |
| Other Non-Current Assets | 3,259 | 3,496 | 3,805 | 4,037 | 4,335 |
| TOTAL | $68,751 | $70,825 | $75,585 | $77,694 | $90,879 |
| Total Assets | $147,216 | $141,436 | $150,000 | $137,623 | $168,826 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,708 | 7,519 | 9,012 | 3,909 | 6,388 |
| Accounts payable and accrued liabilities | 14,673 | 10,580 | 14,667 | 10,987 | 11,130 |
| Accrued Expenses | 49,585 | 41,218 | 41,431 | 44,187 | 58,728 |
| Other current liabilities | 7,450 | 7,833 | 8,094 | 5,359 | 2,911 |
| TOTAL | $85,416 | $67,150 | $73,204 | $64,442 | $80,360 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,386 | 14,533 | 13,560 | 14,279 | 18,404 |
| Other Non-Current Liabilities | 9,502 | 13,936 | 14,888 | 14,594 | 8,918 |
| TOTAL | $20,888 | $28,469 | $28,448 | $28,873 | $27,322 |
| Total Liabilities | $106,304 | $95,619 | $101,652 | $93,315 | $107,682 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,780 | 3,573 | 62,429 | 3,122 | 1,929 |
| Common Shares | N/A | N/A | 0 | N/A | 3 |
| Retained earnings | -301,672 | -294,472 | -287,779 | -287,078 | -270,771 |
| TOTAL | $40,912 | $45,817 | $48,348 | $44,308 | $61,144 |
| Total Liabilities And Equity | $147,216 | $141,436 | $150,000 | $137,623 | $168,826 |